‘Unresolved spinal fractures, peripheral osteoporosis, sarcopenia’: Ex-RCom MD Amitabh Jhunjhunwala granted bail in SBI loan fraud case
State Bank of India is in focus.
30 Sept 2026 · Business Today Mkts
Jhunjhunwala's lawyers argued that these conditions required sustained medical rehabilitation that could not be effectively administered in judicial custody.
The analysis
Against that, the stock is -0.5% on the day at ₹954.00, and has returned -8.7% over three months. It sits 22% below its 52-week high. The banks sector has moved -4.0% over the same period, so State Bank of India is running 4.7 points behind its peers.
For State Bank of India, the question is how much of this is already reflected in the price and how much re-rates the banks peer set alongside it.
Market context
- The company directly in focus is SBIN.
- Sector exposure: Banks.
- The immediate tone of coverage reads negative.
In this story
Related coverage
Invesco and Motilal Oswal lead AUM growth in Q2 FY27, shows data
RBI MPC Decision Live: SBI MD Expects Credit Growth To Remain Strong After Repo Rate Hike
SBI Share Price Live Updates: SBI's Weekly Returns Dip by 0.62%
Up to 52% upside - Jindal SAW, SBI Life, ICICI Bank shares | 360 ONE's21 biggest bets for investors - Check full list
PNB, Kotak Mahindra Bank, other bank stocks rise up to 2% after RBI’s rate hike, Nifty Bank above 55,500